In this process, programmed cell death 1 (PD1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) are the most common targets of ICIs, which generally inhibit the activation and amplification of T cells that render the anti-tumor response ineffective. This evidence concerns the gene PDCD1 and neoplasm.